Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
SHc1SsUX45fYke8h